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Summary
PRINCIPLES: The HOSPITAL score is a simple predic-
tion model that accurately identifies patients at high risk
of readmission and showed good performance in an in-
ternational multicentre retrospective study. We aimed to
demonstrate prospectively its accuracy to predict 30-day
unplanned readmission and death.
METHODS: We prospectively screened all consecutive pa-
tients aged ≥50 years admitted to the department of general
internal medicine of a large community hospital in Switzer-
land. We excluded patients who refused to give consent,
who died during hospitalisation, or who were transferred
to another acute care, rehabilitation or palliative care fa-
cility. The primary outcome was the first unplanned read-
mission or death within 30 days after discharge. Some of
the predictors of the original score (discharge from an on-
cology service and length of stay) were adapted accord-
ing to the setting for practical reasons, before the start of
patient inclusion. We also assessed a simplified version of
the score, without the variable “any procedure performed
during hospitalisation”. The performance of the score was
evaluated according to its overall accuracy (Brier score),
its discriminatory power (C-statistic), and its calibration
(Hosmer-Lemeshow goodness-of-fit test).
RESULTS: Among the 346 included patients, 40 (11.6%)
had a 30-day unplanned readmission or death. The
HOSPITAL score showed very good accuracy (Brier score
0.10), good discriminatory power (C-statistic 0.70, 95%
confidence interval [CI] 0.62–0.79), and an excellent cal-
ibration (p = 0.77). Patients were classified into three risk
categories for the primary outcome: low (59%), interme-
diate (20.8%) and high risk (20.2%). The estimated risks
of unplanned readmission/death for each category were
8.2%, 11.3% and 21.6%, respectively. The simplified score
showed the same performance, with a Brier score of 0.10, a
C-statistic of 0.70 (95% CI 0.61–0.79), and a goodness-of-
fit statistic of 0.40.
CONCLUSIONS: The HOSPITAL score prospectively
identified patients at high risk of 30-day unplanned read-
mission or death with good performance in medical pa-
tients in Switzerland. Its simplicity and good performance
make it an easy-to-use tool to target patients who might
most benefit from intensive transitional care interventions.
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Introduction
Readmissions after an acute care hospitalisation are fre-
quent and associated with significant burden for patients
and healthcare systems. Overall, 14–22% of the patients
are readmitted within 30 days after discharge from an acute
care hospitalisation [1–3]. A recent systematic review
showed that interventions could reduce rates of readmis-
sion, but also that the most successful interventions are the
most complex ones [4]. Therefore, to be efficient, we need
to target these intensive discharge interventions to the pa-
tients with a high risk of readmission. However, clinical
providers are not able to identify accurately which patients
are at high risk for readmission [5].
The HOSPITAL score has been shown to identify accur-
ately medical patients at high risk for 30-day readmission
and is currently one of the best validated readmission pre-
diction models, with good performance shown in five
countries and nearly 150 000 patients [1, 6, 7]. The score
consists of seven variables readily available at discharge,
and allows stratification of the patients before hospital dis-
charge into three categories of risk for readmission. The
HOSPITAL score has yet not been validated prospectively.
A prospective validation study is an essential step in the
level of evidence [8–10]. It also demonstrates the perform-
ance of the score and its practicability in real life.
Moreover, this study would inform about the validity of the
score in another population outside a tertiary care hospit-
al (generalisability). We aimed, therefore, to assess the per-
formance of the HOSPITAL score using a prospective co-
hort of medical patients in Switzerland.
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Methods
Study design and population
We conducted a prospective cohort study between 8 April
and 23 September 2013. We included all consecutive pa-
tients aged ≥50 years admitted to three of seven divisions
of the department of general internal medicine of the Fri-
bourg Cantonal Hospital (115 beds, 4400 admissions/year).
The patient was the unit and was included only once. We
excluded patients who refused or were unable to give in-
formed consent, who died during hospitalisation or who
were transferred to another acute care, rehabilitation or pal-
liative care facility. We aimed to include 350 patients. The
study was approved by the local ethics committee and fol-
lows the criteria from the “Transparent reporting of a mul-
tivariable prediction model for individual prognosis or dia-
gnosis” (TRIPOD) initiative [11].
Outcome
The primary outcome was the first unplanned readmission
and/or death within 30 days after the index hospital dis-
charge. Unplanned readmission was defined as emergent
or urgent, i.e., not scheduled in advance for treatment or
investigation. We contacted all patients by telephone 6
months after the first hospital discharge to identify the first
readmission and/or death. For patients who could not be
reached after several phone call attempts, we called the
primary care physician, family members, close relations,
or the nursing home, as available. Additionally, electronic
patients’ files were checked for any readmission or death
within Fribourg Hospital Network, which includes three
acute care centres (Fribourg, Riaz, Tavel).
Predictor variables
“HOSPITAL” is the acronym for the seven variables in-
cluded in the score (table 1) [1]: Haemoglobin at discharge
(positive if <120 g/l), discharge from an Oncology service,
Sodium level at discharge (positive if <135 mmol/l), any
Procedure performed during the index hospitalization (i.e.
any International Classification of Disease [ICD] coded
procedure), Index admission Type (positive if emergent
or urgent as opposed to elective), number of Admissions
in the previous 12 months (0 point for 0–1 admission,
2 points for 2–5 admissions, and 5 points for >5 admis-
sions), and Length of stay (positive if ≥5 days). Some of
the predictors were adapted according to the study setting
for practical reasons, before the start of patient inclusion.
Because the hospital had no specific oncology division,
the variable “discharge from an oncology service” was re-
placed by “active oncological diagnosis on admission or
during hospitalisation” (i.e. in the past 5 years, including
metastatic and nonmetastatic solid tumors and haematolo-
gical malignancies). The following procedures were con-
sidered: coronary angiography, angioplasty, thromboaspir-
ation, stenting, pacemaker implantation, transoesophagal
echocardiography, oesogastroduodenoscopy, endoscopic
retrograde cholangio-pancreatography, colonoscopy, bron-
choscopy, biopsy, thoracocentesis, lumbar puncture, para-
centesis, chemotherapy, radiotherapy, continuous pressure
ventilation, intubation, transfusion (blood or platelets),
graft, dialysis, operation, suture, electro-neuromyography,
joint aspiration, cystoscopy, bone marrow aspiration/
biopsy, magnetic resonance imaging, computed tomo-
graphy, angiography, positron emission tomography, scin-
tigraphy. Because the mean length of hospital stay is longer
in Switzerland [12] than in the USA [13], where the score
was originally developed, the cut-off for the variable
“length of stay” was increased from ≥5 to ≥8 days, in order
to have the same proportion of patients receiving one point
for this variable. As we recorded admissions in the past 6
months, and not in the past 12 months as originally, the cat-
egories were adapted accordingly as follows: 0 point for
0 admission, 2 points for 1–2 admission(s), and 5 points
for >2 admissions. For haemoglobin and sodium levels, a
blood sample was collected within 24 hours before dis-
charge. We imputed 0 point (= normal) for missing values.
Sodium and haemoglobin were missing for 2 (0.6%) and
3 (0.9%) patients, respectively. Other variables used in the
score and outcome data were available for all the included
patients. The scoring system ranges from a minimum of 0
point to a maximum of 13 points, with a risk of 30-day
unplanned readmission that increases with the number of
points.
We compared the performance of the HOSPITAL score
with another score developed in Canada, in order to evalu-
ate whether the HOSPITAL score has better generalisabil-
ity than another prediction model [14]. We chose the LACE
score because it is one of the best known scores besides
the HOSPITAL score, even though validation studies are
lacking outside Canada. The LACE index was calculated
according to the original derivation study [14]. The LACE
index includes the following variables: length of stay, ad-
mission mode, Charlson comorbidity index score and num-
ber of visits to the emergency department during the last 6
months.
Causes of readmission and death were determined based on
the patients’ or their primary care physicians’ information,
as available, when readmission or death was outside Fri-
bourg Hospital Network.
Statistical analysis
Categorical variables were described as frequency (per-
centage) and continuous variables as mean (standard devi-
ation [SD]) or median (interquartile range [IQR]), as appro-
priate.
The total number of points of the HOSPITAL score was
calculated for each hospital discharge and used to create
three categories of risk for 30-day unplanned readmission
or death: low risk if 0 to 4 point(s), intermediate risk if 5
or 6 points, and high risk if 7 or more points. The predicted
risk of 30-day unplanned readmission or death was estim-
ated according to the HOSPITAL score for each of these
three categories.
The performance of the score was assessed using the fol-
lowing measures:
1. The overall accuracy of the score was assessed with the
Brier score, which evaluates how close predicted rates
are to the observed rates [15, 16]; the lower the Brier
score, the better the prediction model, with a value
<0.25 indicating a useful model [17].
2. The discrimination power of the score was tested with
the C-statistic, which assesses the capacity of the score
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to discriminate between cases and non-cases, according
to sensitivity and specificity of the model [18, 19].
3. The calibration of the score was tested using the
Hosmer-Lemeshow goodness-of-fit statistic, which
evaluates how the model can produce probabilities
matching the actual rates of outcome [16]; a p ≥0.05 re-
flects good fit, and the higher the p-value, the better the
fit.
For each category of risk described above (low, interme-
diate, high), the calibration of the score was examined by
comparing the observed rates of 30-day unplanned read-
mission or death with the estimated risks according to the
HOSPITAL score.
We also looked at the performance of a simplified version
of the HOSPITAL score that excluded the variable “pro-
cedure performed during the index hospitalisation”. This
variable was among the least significant variables in the
previous validation studies [1, 7], and might be more diffi-
cult to capture prospectively than the others.
All tests were conducted as two-sided at a 0.05 level of
significance. All analyses were performed with STATA re-
lease 12.1 (StataCorp LP, College Station, Texas).
Results
During the study period, we included 346 consecutive dis-
charged patients (fig. 1), among whom 40 (11.6%) were re-
admitted or died within 30 days. Among them, 37 had an
unplanned readmission and 5 died (2 died after being re-
admitted). Baseline characteristics of the study population,
according to the occurrence or absence of 30-day readmis-
sion or death, are reported in table 2. Mean age of the pa-
Table 1: HOSPITAL score for 30-day unplanned readmissions, as
developed originally (maximum score: 13 points) [1].
Attribute Value Points
Low Haemoglobin level at discharge (<120 g/l) Yes 1
Discharge from an Oncology service Yes 2
Low Sodium level at discharge (<135 mmol/l) Yes 1
Procedure during the index hospitalisation Yes 1
Index admission Type: urgent or emergent
(nonelective)
Yes 1
Number of hospital Admission(s) during the
previous year
0–1 0
2–5 2
>5 5
Length of stay ≥5 days Yes 2
Figure 1
Study recruitment and outcome.
tients was 73.4 years (SD 11.5), and median length of stay
7 days (IQR 4–12). Comparison of the baseline character-
istics between the derivation study and the current study are
in the appendix (supplementary table S1).
According to the HOSPITAL score, 59.0% of the patients
were classified at low risk, 20.8% at intermediate risk, and
20.2% at high risk of 30-day unplanned readmission or
death. The estimated risks of 30-day readmission or death
were 8.2% for low-risk patients, 11.3% for intermediate-
risk patients and 21.6% for high-risk patients (table 3, sup-
plementary table S2). The p-value of the Hosmer-
Lemeshow goodness-of-fit statistic was 0.77, indicating
excellent calibration. The low Brier score of 0.10 indicated
a very good overall accuracy of the score and the C-statistic
of 0.70 (95% confidence interval [CI] 0.62–0.79) indicated
a good discriminatory power (fig. 2). When taking only the
outcome of unplanned readmission without death, the C-
statistic was 0.68 (95% CI 0.60–0.77).
The simplified score excluding the variable “procedure
performed during the index hospitalisation” showed the
same performance, with a Brier score of 0.10, a C-statistic
of 0.70 (95% CI 0.61–0.79), and a goodness-of-fit statistic
of 0.40.
Only 4.6% (n = 16) of the patients were classified at low
risk for readmission according to the LACE index. The C-
statistic of the LACE index was 0.56 (95% CI 0.46–0.66).
The calibration was, however, good with a p-value for
Hosmer-Lemeshow goodness-of-fit statistic of 0.88.
The most common primary diagnoses at admission were
cardiovascular disorders (26.6%), infectious disorders
(20.2%) and neurological and psychiatric disorders
(19.0%). Among the patients who presented the primary
outcome, 10 were readmitted for cancer, 7 for an infectious
disorder and 5 for a respiratory disorder, while 3 died of
cancer and 2 of respiratory disorder.
Figure 2
Receiver operating characteristic (ROC) curve for readmission or
death within 30 days after hospital discharge.
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Discussion
In this study including 346 adult medical patients, we pro-
spectively and externally validated the HOSPITAL score
for predicting 30-day unplanned readmission or death. The
score showed good performance, with a very good overall
accuracy (Brier score 0.10), a good discriminatory power
(C-statistic 0.70) and an excellent calibration (p-value for
Hosmer-Lemeshow goodness-of-fit test 0.77). Among the
20.2% patients classified at high risk of unplanned read-
mission or death within 30 days after discharge, 21.6%
were identified as at risk of readmission or death, and
20.0% were actually readmitted and/or died. The
HOSPITAL score also had performed better than the LACE
index in this population.
We observed an 11.6% (40/346) rate of unplanned read-
mission or death, which is consistent with previous data
[1, 3, 20]. Although our study population characteristics
were different from the original derivation and validation
study, the performance of the HOSPITAL score was sim-
ilar, which indicates a very good generalisability of the
score. Our study population was older (mean age 73.4 vs
61.3 years), had more nonelective admissions (96 vs 87%),
had fewer patients with at least one procedure performed
during the index hospitalisation (40 vs 72%), had less an-
aemia at discharge (44 vs 61%), and had more patients with
a negative history of hospitalisation before index admission
(72% vs 47% in the original study, although the timeframe
was different). As expected, the length of stay was longer
in our study (73% were hospitalised for more than 4 days,
vs 44% in the original study), which is consistent with pre-
vious data showing that hospital stay is longer in Switzer-
land than in the USA [1, 12, 13], and supports the need to
adapt the points imputed for the variable “length of stay”
according to the country. In terms of calibration, the abso-
lute proportions in each risk group were somewhat differ-
ent from the original study (59 % vs 49%, 21% vs 26% and
20% vs 24% in the low-, intermediate-, and high-risk cat-
egories, respectively). However, the overall concordance
within each decile was excellent, as shown by the Hosmer-
Lemeshow goodness-of-fit statistic. Despite these differen-
ces between our study and the original study, we found a
similar discriminatory power (0.70 vs 0.71), and a better
goodness-of-fit than in the original study (p = 0.77 vs p
= 0.15). We may therefore assume a wide generalisabil-
ity of the HOSPITAL score to different patient populations
and settings, as differences in the proportions of patients
presenting the different items of the score did not invalid-
ate its performance.
Previous studies associated cancer with hospital readmis-
sion [21–23]. In the derivation study of the HOSPITAL
score also, being discharged from an oncology service was
associated with a high risk of unplanned readmission [1].
Although a diagnosis of cancer was significantly associated
with 30-day readmission in the original derivation study,
the choice of “discharge from an oncology division” was
made because this variable could be easier to collect than
a diagnosis of cancer. However, not all hospitals have an
oncology division, and we showed here that the diagnosis
of a recent cancer can also be used instead of the oncology
division. We also showed in our population that the vari-
able “any procedure performed during the hospital stay”
may be left out if difficult to collect, without reducing the
score performance. The discrimination power was indeed
identical with or without this variable (C-statistic 0.70) in
our study. This simplified version of the HOSPITAL score
may allow wider and easier implementation in everyday
clinical practice.
Table 2: Baseline characteristics of the study population stratified according to the occurrence or absence of readmission or death within 30 days after discharge.
Clinical characteristics Entire cohort
(n = 346)
Without 30-day readmission/
death
(n = 306)
With 30-day readmission/
death
(n = 40)
Age, mean (SD) 73.4 (11.5) 73.3 (11.7) 71.2 (10.1)
Male gender, n (%) 172 (49.7) 151 (49.4) 21 (52.5)
Charlson comorbidity index, mean (SD) 6.9 (2.8) 6.7 (2.7) 8.1 (3.2)
Urgent or emergent index admission, n (%) 333 (96.2) 295 (96.4) 38 (95.0)
Oncology diagnosis, n (%) 83 (24.0) 65 (21.2) 18 (45.0)
Length of stay of the index hospitalisation ≥8 days, n (%) 160 (46.2) 142 (46.4) 18 (45.0)
Number of hospital admissions in the past 6 months, n (%)
0 248 (71.7) 225 (73.5) 23 (57.5)
1–2 83 (24.0) 72 (23.5) 11 (27.5)
>2 15 (4.3) 9 (2.9) 6 (15.0)
≥1 procedure during the index hospitalisation, n (%) 248 (71.7) 219 (71.6) 29 (72.5)
Low haemoglobin level at discharge (<120 g/l), n (%) 152 (43.9) 128 (41.8) 24 (60.0)
Low sodium level at discharge (<135 mmol/l), n (%) 36 (10.4) 30 (9.8) 6 (15.0)
SD = standard deviation
Table 3: Observed proportions versus estimated risk of 30-day unplanned readmission or death.
Points* Risk category Number of patients in each category
n (%)
Observed proportion with readmission or
death in the validation study
%
Estimated risk of readmission or death in
the validation study using the HOSPITAL
score
%
0–4 Low 204 (59.0) 9.8 8.2
5–6 Intermediate 72 (20.8) 8.3 11.3
≥7 High 70 (20.2) 20.0 21.6
* According to the HOSPITAL score [1].
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The HOSPITAL score has several advantages. First, it per-
forms overall better than most of the previously derived
scores [24]. In this study, we also showed that the LACE
score had a lower discriminatory power in comparison with
the HOSPITAL score (C-statistic 0.56 vs 0.70). The su-
periority of the HOSPITAL score in comparison with the
LACE score has also been recently showed in two hospitals
in Denmark [6]. Second, it can be applied to any medical
patient, regardless of the main diagnosis, as opposed to
scores derived for specific diseases only [25–28]. Third,
the predictors used to calculate the score are easily avail-
able before discharge. Fourth, it predicts the outcome with-
in 30 days after discharge; we can indeed suppose that
readmissions and deaths within a longer time frame may
be less closely related to the index hospitalisation. Finally,
after having been largely validated retrospectively in five
countries and nearly 150 000 patients [7], it has been now
validated prospectively.
This study had some strengths. First, we recorded readmis-
sions that occurred within any hospital and not only in-
side our hospital network. Second, we also recorded deaths
occurring after discharge, hypothesising that patients who
died might have been readmitted if they had not died.
Third, we had no missing data for the outcome of interest,
and only very few missing data for the variables included
in the score. Finally, all variables were recorded prospect-
ively, which demonstrates the practicability of the score in
real-life, and provides a high evidence level to the predic-
tion model [8].
We must, however, mention some limitations. First, the
sample size was relatively small and the study was con-
ducted at a single centre. Second, unplanned readmissions
were not defined according to a validated algorithm, but
to hospital or patient reports only. Third, we had no onco-
logy service and recorded hospitalisation during the past 6
months only, and therefore had to slightly adapt the score
accordingly; however, it obviously did not distort the per-
formance of the score. Finally, as a result of the prospective
design, the outcome of readmission was based on patient-
reported hospital outcomes. On one hand, the prospective
study design allowed us to contact all participants in order
to capture all first readmissions to any hospital as men-
tioned above. This is a major advantage in comparison with
a retrospective study design where only readmissions to the
same hospital can be typically captured. On the other hand,
the patients might not remember all the events.
Implications and conclusion
In this prospective study, we validated the good perform-
ance of the HOSPITAL score to predict unplanned read-
missions and deaths within 30 days after hospital discharge
in medical patients. This score uses predictors that are
readily available before discharge and could, therefore, be
easily implemented in the daily clinical practice. The
HOSPITAL score may help clinicians to target more in-
tensive transitional care interventions at the patients who
are most likely to benefit, in order to efficiently reduce the
negative burden of readmission.
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Appendix: Supplementary tables
Table S1: Comparison of the baseline characteristics between the original derivation study in the USA and the prospective external validation study in Switzerland.
Clinical characteristics Entire original
cohort
(n = 9212)
Without
30-day PAR in
the original
derivation
cohort
(n = 5553)
With 30-day
PAR in the
original
derivation
cohort
(n = 588)
Entire cohort
(n = 346)
Without
30-day
readmission/
death
(n = 306)
With 30-day
readmission/
death
(n = 40)
Age, mean (SD) 61.3 NA NA 73.4 (11.5) 73.3 (11.7) 71.2 (10.1)
Male gender, n (%) 4476 (48.6) 2652 (47.8) 282 (48.0) 172 (49.7) 151 (49.4) 21 (52.5)
Charlson comorbidity index, mean (SD) NA NA NA 6.9 (2.8) 6.7 (2.7) 8.1 (3.2)
Urgent or emergent index admission, n (%) 8021 (87.1) 4817 (86.7) 524 (89.1) 333 (96.2) 295 (96.4) 38 (95.0)
Oncology diagnosis, n (%) 2192 (23.8) 1204 (21.7) 232 (39.5) 83 (24.0) 65 (21.2) 18 (45.0)
Long length of stay of the index hospitalization, n (%) 4031 (43.8) 2301 (41.1) 329 (56.0) 160 (46.2) 142 (46.4) 18 (45.0)
Number of hospital admissions in the past year (original study) /
past 6 months (validation study), n (%)
0 4321 (46.9) 2698 (48.6) 178 (30) 248 (71.7) 225 (73.5) 23 (57.5)
1–5 / 1–2 4456 (48.4) 2629 (47.3) 344 (58.5) 83 (24.0) 72 (23.5) 11 (27.5)
>5 / >2 435 (4.7) 226 (4.1) 66 (11) 15 (4.3) 9 (2.9) 6 (15.0)
≥1 procedure during the index hospitalisation, n (%) 5576 (60.5) 3290 (59.2) 411 (69.9) 248 (71.7) 219 (71.6) 29 (72.5)
Low haemoglobin level at discharge (< 120 g/l), n (%) 5626 (61.1) 3761 (61.2) 481 (81.8) 152 (43.9) 128 (41.8) 24 (60.0)
Low sodium level at discharge (< 135 mmol/l), n (%) 1454 (15.8) 832 (15.0) 137 (23) 36 (10.4) 30 (9.8) 6 (15.0)
NA = not available; PAR = potentially avoidable readmission; SD = standard deviation
Table S2: Comparison between the observed proportions versus estimated risk of readmission in the original derivation study and the prospective external validation study.
Points* Risk category Number of patients
in each category in
the derivation
study
n (%)
Observed
proportion with
readmission or
death in the
derivation study
%
Estimated risk of
readmission or
death in the
derivation study
using the
HOSPITAL score
%
Number of patients
in each category
n (%)
Observed
proportion with
readmission or
death in the
validation study
%
Estimated risk of
readmission or
death in the
validation study
using the
HOSPITAL score
%
0–4 Low 3027 (49.3) 5.4 5.2 204 (59.0) 9.8 8.2
5–6 Intermediate 1617 (26.3) 9.0 9.8 72 (20.8) 8.3 11.3
≥7 High 1497 (24.4) 18.7 18.3 70 (20.2) 20.0 21.6
* According to the HOSPITAL score
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Figures (large format)
Figure 1
Study recruitment and outcome.
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Figure 2
Receiver operating characteristic (ROC) curve for readmission or death within 30 days after hospital discharge.
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